These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 25311255)

  • 1. Analysis of associations between polymorphisms within genes coding for tumour necrosis factor (TNF)-alpha and TNF receptors and responsiveness to TNF-alpha blockers in patients with rheumatoid arthritis.
    Swierkot J; Bogunia-Kubik K; Nowak B; Bialowas K; Korman L; Gebura K; Kolossa K; Jeka S; Wiland P
    Joint Bone Spine; 2015 Mar; 82(2):94-9. PubMed ID: 25311255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of polymorphisms in TRAILR1 and TNFR1A on the response to anti-TNF therapies in patients with rheumatoid and psoriatic arthritis.
    Morales-Lara MJ; Cañete JD; Torres-Moreno D; Hernández MV; Pedrero F; Celis R; García-Simón MS; Conesa-Zamora P
    Joint Bone Spine; 2012 Dec; 79(6):591-6. PubMed ID: 22480748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour necrosis factor alpha -308G->A polymorphism is not associated with response to TNFalpha blockers in Caucasian patients with rheumatoid arthritis: systematic review and meta-analysis.
    Pavy S; Toonen EJ; Miceli-Richard C; Barrera P; van Riel PL; Criswell LA; Mariette X; Coenen MJ
    Ann Rheum Dis; 2010 Jun; 69(6):1022-8. PubMed ID: 19966089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of anti-CCP positivity and carriage of TNFRII susceptibility variant with anti-TNF-α response in rheumatoid arthritis.
    Vasilopoulos Y; Bagiatis V; Stamatopoulou D; Zisopoulos D; Alexiou I; Sarafidou T; Settas L; Sakkas L; Mamouris Z
    Clin Exp Rheumatol; 2011; 29(4):701-4. PubMed ID: 21813066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of variants of Fc gamma receptors IIA and IIIA on the American College of Rheumatology and European League Against Rheumatism responses to anti-tumour necrosis factor alpha therapy in rheumatoid arthritis.
    Cañete JD; Suárez B; Hernández MV; Sanmartí R; Rego I; Celis R; Moll C; Pinto JA; Blanco FJ; Lozano F
    Ann Rheum Dis; 2009 Oct; 68(10):1547-52. PubMed ID: 18930989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between anti-tumour necrosis factor treatment response and genetic variants within the TLR and NF{kappa}B signalling pathways.
    Potter C; Cordell HJ; Barton A; Daly AK; Hyrich KL; Mann DA; Morgan AW; Wilson AG; ; Isaacs JD
    Ann Rheum Dis; 2010 Jul; 69(7):1315-20. PubMed ID: 20448286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of a polymorphism at position -857 of the tumour necrosis factor alpha gene on clinical response to etanercept therapy in rheumatoid arthritis.
    Kang CP; Lee KW; Yoo DH; Kang C; Bae SC
    Rheumatology (Oxford); 2005 Apr; 44(4):547-52. PubMed ID: 15695296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between tumor necrosis factor-alpha (TNF-alpha) -308 and -238 G/A polymorphisms and shared epitope status and responsiveness to TNF-alpha blockers in rheumatoid arthritis: a metaanalysis update.
    Lee YH; Ji JD; Bae SC; Song GG
    J Rheumatol; 2010 Apr; 37(4):740-6. PubMed ID: 20194454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variants within the TNFRSF1B gene and susceptibility to rheumatoid arthritis and response to anti-TNF drugs: a multicenter study.
    Canet LM; Filipescu I; Cáliz R; Lupiañez CB; Canhão H; Escudero A; Segura-Catena J; Soto-Pino MJ; Ferrer MA; García A; Romani L; Pérez-Pampin E; González-Utrilla A; López Nevot MA; Collantes E; Fonseca JE; Sainz J
    Pharmacogenet Genomics; 2015 Jul; 25(7):323-33. PubMed ID: 25850964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association analysis of single nucleotide polymorphisms of proinflammatory cytokine and their receptors genes with rheumatoid arthritis in northwest Chinese Han population.
    You CG; Li XJ; Li YM; Wang LP; Li FF; Guo XL; Gao LN
    Cytokine; 2013 Jan; 61(1):133-8. PubMed ID: 23148991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of the tumour necrosis factor-308 variant with differential response to anti-TNF agents in the treatment of rheumatoid arthritis.
    Maxwell JR; Potter C; Hyrich KL; ; Barton A; Worthington J; Isaacs JD; Morgan AW; Wilson AG
    Hum Mol Genet; 2008 Nov; 17(22):3532-8. PubMed ID: 18713756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients.
    Canet LM; Sánchez-Maldonado JM; Cáliz R; Rodríguez-Ramos A; Lupiañez CB; Canhão H; Martínez-Bueno M; Escudero A; Segura-Catena J; Sorensen SB; Hetland ML; Soto-Pino MJ; Ferrer MA; García A; Glintborg B; Filipescu I; Pérez-Pampin E; González-Utrilla A; Nevot MÁL; Conesa-Zamora P; Broeder AD; De Vita S; Jacobsen SEH; Collantes-Estevez E; Quartuccio L; Canzian F; Fonseca JE; Coenen MJH; Andersen V; Sainz J
    Pharmacogenomics J; 2019 Feb; 19(1):83-96. PubMed ID: 30287909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of rheumatoid arthritis susceptibility genes identifies association of AFF3 and CD226 variants with response to anti-tumour necrosis factor treatment.
    Tan RJ; Gibbons LJ; Potter C; Hyrich KL; Morgan AW; Wilson AG; Isaacs JD; ; Barton A
    Ann Rheum Dis; 2010 Jun; 69(6):1029-35. PubMed ID: 20444755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single tumour necrosis factor haplotype influences the response to adalimumab in rheumatoid arthritis.
    Miceli-Richard C; Comets E; Verstuyft C; Tamouza R; Loiseau P; Ravaud P; Kupper H; Becquemont L; Charron D; Mariette X
    Ann Rheum Dis; 2008 Apr; 67(4):478-84. PubMed ID: 17673491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic Variations in Pattern Recognition Receptor Loci Are Associated with Anti-TNF Response in Patients with Rheumatoid Arthritis.
    Sode J; Vogel U; Bank S; Andersen PS; Hetland ML; Locht H; Heegaard NH; Andersen V
    PLoS One; 2015; 10(10):e0139781. PubMed ID: 26440629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms in STAT4, PTPN2, PSORS1C1 and TRAF3IP2 Genes Are Associated with the Response to TNF Inhibitors in Patients with Rheumatoid Arthritis.
    Conigliaro P; Ciccacci C; Politi C; Triggianese P; Rufini S; Kroegler B; Perricone C; Latini A; Novelli G; Borgiani P; Perricone R
    PLoS One; 2017; 12(1):e0169956. PubMed ID: 28107378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour necrosis factor 5' promoter single nucleotide polymorphisms influence susceptibility to rheumatoid arthritis (RA) in immunogenetically defined multiplex RA families.
    Waldron-Lynch F; Adams C; Amos C; Zhu DK; McDermott MF; Shanahan F; Molloy MG; O'Gara F
    Genes Immun; 2001 Apr; 2(2):82-7. PubMed ID: 11393661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-TNF treatment response in rheumatoid arthritis patients is associated with genetic variation in the NLRP3-inflammasome.
    Sode J; Vogel U; Bank S; Andersen PS; Thomsen MK; Hetland ML; Locht H; Heegaard NH; Andersen V
    PLoS One; 2014; 9(6):e100361. PubMed ID: 24967817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of CD94 and NKG2A variants on susceptibility to rheumatoid arthritis and efficacy of anti-TNF treatment.
    Iwaszko M; Świerkot J; Kolossa K; Jeka S; Wiland P; Bogunia-Kubik K
    Joint Bone Spine; 2016 Jan; 83(1):75-9. PubMed ID: 26453102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of TNF-alpha -308 G/A polymorphism with responsiveness to TNF-alpha-blockers in rheumatoid arthritis: a meta-analysis.
    Lee YH; Rho YH; Choi SJ; Ji JD; Song GG
    Rheumatol Int; 2006 Dec; 27(2):157-61. PubMed ID: 16909270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.